In its first-quarter 2025 investor letter, Upslope Capital Management highlighted stocks such as Charles River Laboratories International, Inc. (NYSE:CRL). Charles River Laboratories International ...

Below is Validea's guru fundamental report for CHARLES RIVER LBRTRS NTRNTL INC (CRL). Of the 22 guru strategies we follow, CRL rates highest using our Shareholder Yield Investor model based on the ...

In trading on Tuesday, shares of Charles River Laboratories International Inc. (Symbol: CRL) entered into oversold territory, hitting an RSI reading of 29.8, after changing hands as low as $105.18 ...

Tab-cel, the company’s novel T-cell immunotherapy, is already marketed in the EU under the brand name ... Atara clarified that the FDA’s CRL was exclusively linked to observations from ...

1 Day CRL 1.73% DJIA -1.33% S&P 500 0.13% Health Care/Life Sciences 0.14% ...

1 Day CRL 1.73% DJIA -1.33% S&P 500 0.13% Health Care/Life Sciences -0.86% ...